Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Hormel Foods Corporation due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Class Action - Shareholders who purchased Hormel securities may be entitled to compensation through a contingency fee arrangement, with Rosen Law Firm preparing a class action to recover investor losses [2]. - Investors can join the prospective class action by submitting a form or contacting the law firm directly for more information [2]. Group 2: Recent Company Developments - On October 29, 2025, Hormel Foods announced a cut in its earnings forecast due to price pressures, bird flu, and a fire at its Arkansas peanut butter production facility, leading to a 9.1% drop in its stock price [3]. - The company also announced the departure of its Chief Financial Officer as part of this news [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for the number of settlements since 2013 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Zions Bancorporation due to allegations of materially misleading business information issued by the company [1] Group 1: Legal Actions and Investigations - Shareholders who purchased Zions Bancorporation securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2] - Zions Bancorporation announced a $50 million charge-off related to a loan underwritten by its subsidiary, California Bank & Trust, citing misrepresentations and contractual defaults [3] - An independent review of the matter will be coordinated by Zions Bancorporation with legal counsel [3] Group 2: Market Reaction - Following the announcement of the charge-off, Zions Bancorporation's common stock experienced a decline of 13.14% on October 16, 2025 [4] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [5] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [5]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Action and Investor Rights - Investors who purchased Tandem Diabetes Care securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to the misleading information [2]. Group 2: Company Incident and Stock Impact - On August 7, 2025, Tandem Diabetes Care announced a voluntary medical device correction for select t:slim X2 insulin pumps, addressing a potential speaker-related issue that could lead to insulin delivery discontinuation [3]. - Following this announcement, Tandem Diabetes' stock experienced a significant decline of 19.9% on the same day [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - Jefferies Financial Group Inc. and its trade finance arm Point Bonita Capital are under investigation for potential violations of federal securities laws related to their significant exposure to First Brands Group, which recently filed for bankruptcy [1][2][4]. Group 1: Company Overview - Jefferies is an investment banking and capital markets firm, while Point Bonita Capital serves as its trade finance division [2]. - Both firms were closely associated with First Brands Group, an auto parts supplier that collapsed into bankruptcy in September 2025 [2]. Group 2: Financial Exposure - On October 8, 2025, Jefferies disclosed that it and Point Bonita had approximately $715 million in exposure to First Brands' receivables, accounting for about 25% of Point Bonita's trade finance portfolio [3]. - Following this announcement, Jefferies' stock price dropped by $4.66 per share, or approximately 8%, from $59.10 on October 7, 2025, to $54.44 on October 8, 2025 [3]. Group 3: Legal Investigation - Bleichmar Fonti & Auld LLP is investigating whether Jefferies and/or Point Bonita made materially false and misleading statements to investors regarding their exposure to First Brands [4].

NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coty Inc. (NYSE: COTY) for potential violations of the federal securities laws. If you invested in Coty, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/coty-inc-class-action. Why Is Coty being Investigated?Coty is one of the world’s largest beauty companies with a portfolio of brands across fragrance, color cosmetics, and skin and b ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Quanex Building Products Corporation during the specified class period of the upcoming lead plaintiff deadline on November 18, 2025 [2][8]. Group 1: Class Action Details - Investors who purchased Quanex securities between December 12, 2024, and September 5, 2025, may be entitled to compensation through a contingency fee arrangement [3][4]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the deadline [4][9]. Group 2: Case Allegations - The lawsuit alleges that Quanex made false and misleading statements regarding its tooling and equipment maintenance policies, particularly in its Tyman Mexico facility, which were significantly underinvested [6]. - It is claimed that the conditions of the tooling and equipment had degraded to near catastrophic levels, leading to significant costs and delays in expected benefits from the Tyman integration [6]. - The lawsuit asserts that Quanex had previously identified these issues, and the positive statements made by the defendants about the company's business and prospects were materially misleading [6]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [5]. - The firm has recovered hundreds of millions of dollars for investors and was ranked No. 1 for securities class action settlements in 2017 [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased DexCom, Inc. securities between July 26, 2024, and September 17, 2025, about the upcoming lead plaintiff deadline for a class action lawsuit set for December 29, 2025 [1]. Group 1: Class Action Details - Investors who bought DexCom securities during the specified period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the court by December 29, 2025 [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company and has been ranked highly for its performance in this area [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [4]. Group 3: Case Allegations - The lawsuit alleges that DexCom made unauthorized design changes to its G6 and G7 continuous glucose monitoring systems, which compromised their reliability and posed health risks to users [5]. - It is claimed that the company overstated the enhancements and reliability of the G7 devices while downplaying the severity of the issues [5]. - The allegations suggest that these misrepresentations subjected DexCom to increased regulatory scrutiny and potential legal repercussions, leading to investor damages when the truth was revealed [5].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of America's Car-Mart, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Legal Action - Shareholders who purchased America's Car-Mart, Inc. securities may be entitled to compensation through a contingency fee arrangement, with a class action being prepared to recover investor losses [2]. - The investigation follows a significant stock price drop of 18.2% on September 4, 2025, after the company reported a first-quarter loss of 69 cents per share, compared to a net loss of 15 cents per share in the previous year [3]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering hundreds of millions of dollars for investors [4]. - The firm has been recognized for its performance in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].

New York, New York--(Newsfile Corp. - November 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Firefly Aerospace Inc. (NASDAQ: FLY) resulting from allegations that Firefly Aerospace may have issued materially misleading business information to the investing public.SO WHAT: If you purchased Firefly Aerospace securities you may be entitled to compensation without payment of any out of pocket fees or cost ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Hormel Foods Corporation due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Class Action - Shareholders who purchased Hormel securities may be entitled to compensation through a contingency fee arrangement, with no out-of-pocket costs [2]. - Rosen Law Firm is preparing a class action to seek recovery of investor losses [2]. Group 2: Recent Developments - On October 29, 2025, The Wall Street Journal reported that Hormel cut its earnings forecast due to price pressures, bird flu, and a fire at its Arkansas peanut butter production facility, leading to a 9.1% drop in stock price [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4].